BESPONSA subst sèche 1 mg flac

7680660220012 CH-66022 L01FB01 07.16.1.

Reimbursement limitations:

BESPONSA

Conformément à la garantie de prise en charge par l’assureur-maladie après consultation préalable auprès du …

BESPONSA subst sèche 1 mg flac
BESPONSA subst sèche 1 mg flac
BESPONSA subst sèche 1 mg flac
1 / 3
google

Details

Product number
6602201
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
inotuzumabum ozogamicinum 1 mg, trometamolum, saccharum, polysorbatum 80, natrii chloridum, pro vitro corresp. natrium 0.9441 mg.

Articles (1)

Besponsa 1mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/07/2024
Professional SmPC
Français
16/07/2024
Professional SmPC
Italien
16/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.9441 MG Substance HBESI

Reimbursement information

Public price
CHF 11762.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2018

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
66022
Drug name
Besponsa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPA
ATC Code
L01FB01
Authorization status
Z
Dispensation category
A
First authorization
10/07/2017
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
akute lymphoblastische Leukämie

Packaging details

Description (FR)
BESPONSA subst sèche 1 mg flac
Description (DE)
BESPONSA Trockensub 1 mg Durchstf
Market launch
10/07/2017
Narcotic (BTM)
No